2nd Quarter - Report

MASIMO CORPORATION for MASIMO CORPORATION

Period 2nd Quarter 2019 Filed Jul 22, 2019 Signed by Catherine Meier

Official filing
Firm
MASIMO CORPORATION
Client
MASIMO CORPORATION
Income
—
Expenses
$60,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Support for continuous monitoring of patients taking opioids. S.1227, HR 2376 - Prescription Pricing for the People Act of 2019; Government Purchasing Organizations (GPOs) and anticompetitive behavior

LobbyistCovered position, as disclosed
CATHERINE MEIER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office

Bills named: H.R. 2376 (116th), S. 1227 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.